Affiliate disclosure: The RX Index earns a commission when you sign up with some of the providers mentioned on this page. It does not affect what you pay, and it never determines our rankings or which providers we cover. Read the full disclosure.
Wegovy Guide · May 4, 2026 · Label-Verified
What Happens When You Stop Wegovy: Your 2026 Off-Ramp Plan
Published:
By The RX Index Editorial Team
Last verified: · Wegovy prescribing information checked · 14-minute read · See sources
The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. We don't sell Wegovy, we don't manufacture it, and we don't write paid placements as editorial. We compare providers and access paths that work for real patients in 2026.
What happens when you stop Wegovy
It is more predictable than scary — and very different from drug withdrawal. The Wegovy prescribing information says semaglutide has an elimination half-life of about 1 week and stays in circulation for about 5 to 7 weeks after the last 2.4 mg or 7.2 mg injection or 25 mg oral dose. As it fades, hunger and “food noise” usually come back. In the STEP 1 extension trial, people regained roughly two-thirds of their lost weight within a year of stopping if they had no continuation plan — but that is an average, not a destiny.
If you're here, you're probably one of these people:
- →Your insurance just stopped covering Wegovy.
- →You hit your goal weight and don't know if you have to stay on this forever.
- →You already stopped and the scale is moving the wrong way.
- →A pregnancy or surgery is forcing the conversation.
- →The side effects got too rough.
- →You missed a dose or three and you're not sure how to restart.
This guide is built for all six situations. Skip to whichever section matches you. The early sections answer the universal questions — timeline, regain, withdrawal — and the later sections handle each specific situation.
What happens when you stop Wegovy? Start here
The biggest mistake people make when stopping Wegovy is treating “stop” as one decision. It is actually six different decisions, and the right next step depends entirely on why you are stopping.
| Your situation | First move | What not to do |
|---|---|---|
| Missed 1 weekly Wegovy injection | Take it now if your next dose is more than 2 days away; skip it if less than 2 days away. | Don't double up. |
| Missed 2+ weekly injections | Ask your prescriber whether to resume your usual dose or restart lower. | Don't restart at a high dose without checking. |
| Insurance stopped covering it | Check coverage and cash-pay options before you create a medication gap. | Don't assume your only option is quitting. |
| Side effects forced the stop | Distinguish between dose-related side effects (often fixable) and red-flag symptoms (urgent). | Don't ignore severe abdominal pain, persistent vomiting, or signs of dehydration. |
| You hit your goal weight | Build a maintenance plan before you stop, not after the regain starts. | Don't stop without a regain trigger you've defined in advance. |
| Planning a pregnancy | Stop at least 2 months before trying to conceive (per the Wegovy label). | Don't keep taking it while trying to conceive unless your provider says so. |
| Surgery is scheduled | Tell your surgical and anesthesia team early. | Don't hide GLP-1 use from anesthesia. |
| You just want off the meds | Build a 90-day off-ramp plan instead of cold-stopping. | Don't expect willpower alone to outperform the biology. |
Not sure which row above is yours? Take our free 60-second quiz — it matches you to a specific next step based on your dose, your situation, and your reason for stopping.
Take our free 60-second GLP-1 path quiz →How long does Wegovy stay in your system after the last dose?
Answer
Wegovy contains semaglutide, which has an elimination half-life of about one week. According to the Wegovy prescribing information, the medication remains in circulation for about 5 to 7 weeks after the last 2.4 mg or 7.2 mg injection or 25 mg oral dose.
| Time after last dose | Approximate % remaining | What you may notice |
|---|---|---|
| Week 1 | ~50% | Side effects may begin to ease slightly |
| Week 2 | ~25% | Appetite suppression still partially active |
| Week 3 | ~12% | Food noise may start returning |
| Week 5 | ~3% | Medication effect mostly faded |
| Week 7 | <1% | Drug functionally cleared |
| Source: Wegovy prescribing information. Half-life math applied to 7-day elimination half-life. | ||
You will not feel a sharp “off” moment. Many people still feel partial appetite suppression two or three weeks after their last shot, then notice food noise getting louder somewhere in the middle of the clearance window, and feel “fully off” by week 7.
“Still in your system” is not the same as “still working at full strength.” A small amount of semaglutide can remain detectable for weeks while the appetite-suppressing effect has mostly faded.
One important note: the Wegovy label tells patients to discontinue at least 2 months before a planned pregnancy — specifically because semaglutide has a long half-life. The label also states no clinically significant pharmacokinetic differences were observed based on body weight, renal impairment (eGFR 30 to <90), or mild, moderate, or severe hepatic impairment.
Does stopping Wegovy cause withdrawal?
Answer
No dependence-style withdrawal syndrome is described in the Wegovy prescribing information. What people commonly call “Wegovy withdrawal” is usually rebound appetite — hunger, cravings, and food noise returning as the medication effect fades.
Withdrawal is what happens when your brain has adapted to a substance and reacts negatively to its absence (think opioids, benzodiazepines, alcohol). The Wegovy label does not describe that pattern. What actually happens is rebound — the biology Wegovy was suppressing comes back online.
What people typically experience after stopping:
- •GI side effects ease as the drug level falls. The 7-day half-life means drug levels drop quickly week over week.
- •Appetite returns gradually over weeks 2–6. You'll often notice it first as 'I'm hungry sooner than I used to be.'
- •Food noise comes back. This is the constant intrusive thoughts about eating that Wegovy quiets. When it returns, it can feel jarring.
- •Mood and energy are sometimes mentioned anecdotally, but they're not well-documented as direct effects of stopping in the clinical literature.
What you should NOT brush off
If any of these happen after stopping Wegovy, contact your provider:
- !Severe abdominal pain (especially if it spreads to your back) — possible pancreatitis
- !Persistent vomiting or diarrhea with signs of dehydration — risk of acute kidney injury
- !Yellow skin or eyes, severe right-side belly pain — possible gallbladder issue
- !Allergic reaction signs (swelling, hives, trouble breathing)
- !Sudden, repeated low blood sugar episodes if you're diabetic and on insulin or sulfonylureas
How much weight will I regain after stopping Wegovy?
Answer
On average, people regain about two-thirds of their Wegovy weight loss within a year of stopping if they don't have a continuation plan. New 2026 data from the BMJ shows that weight returns roughly four times faster after stopping a weight-loss medication than after stopping a diet-only program. Your individual outcome depends on how much you lost, how long you were on it, and what infrastructure you build after.
The regain evidence map
| Study | Population | Regain result | What it does NOT prove |
|---|---|---|---|
| STEP 1 Extension (Wilding et al., Diabetes Obes Metab, 2022) | 327 adults with overweight/obesity, no diabetes | Lost 17.3% on treatment; regained 11.6 pp after stopping; net 5.6% off baseline at week 120 — about two-thirds regained | What happens with structured continuation |
| STEP 4 (Rubino et al., JAMA, 2021) | 803 adults — half continued semaglutide, half switched to placebo after 20-week run-in | Continued group: −7.9% additional loss. Placebo-switch group: +6.9% gain | Outcomes past one year |
| BMJ 2026 meta-analysis (West et al.) | 9,341 adults across 37 studies, 13 weight-loss medications | ~0.4 kg/month overall; ~0.8 kg/month for newer incretins; ~4× faster than behavioral-only stopping | Individual outcome — variation is wide |
The damaging admission
Most studies on stopping Wegovy show meaningful regain. Lifestyle alone does not reliably replace a GLP-1 — the BMJ 2026 meta-analysis directly documented that regain after newer incretin medications is roughly four times faster than regain after a behavior-only program, even when habits are similar.
Now here is the part that should give you back some control: the average does not decide your outcome. The thing that changes the outcome is rarely “willpower.” It is usually structure.
Should you taper Wegovy or stop cold turkey? The four off-ramp paths
Answer
The Wegovy prescribing information includes dose-escalation, missed-dose, and form-switch rules, but it does not include a formal taper-off schedule. “Taper or cold turkey” is the wrong first question. The right question is why you are stopping — that determines which of four paths fits.
Continue at a clinician-directed lower dose
- Best for:
- You hit your goal weight and want to keep most of the loss. You can afford continuation.
- Outlook:
- Strongest regain protection in the available data. STEP 4 showed continued semaglutide patients kept losing weight; placebo-switch patients gained.
- Trade-off:
- You are still on a medication, with all the practical and financial implications.
Switch to the Wegovy pill (oral semaglutide)
- Best for:
- Needle fatigue or oral preference.
- Outlook:
- The Wegovy label says patients on 2.4 mg injection may start the 25 mg oral tablet one week after their last injection. In Study 7, the 25 mg tablet produced −13.6% body weight change vs −2.4% with placebo at week 64.
- Trade-off:
- Must be taken on an empty stomach with a 30-minute wait. The label-aligned switch from 2.4 mg injection is to the 25 mg tablet — which is $299/month, not the $149 starting-dose price.
Step up to Wegovy 7.2 mg HD
- Best for:
- You've tolerated 2.4 mg for at least 4 weeks and still need additional weight reduction. The label specifically supports this transition.
- Outlook:
- This isn't really 'stopping' — it's a continuation conversation for patients who haven't hit their goal yet.
- Trade-off:
- The side effect difference is real. Nausea: 39% at 7.2 mg vs 35% at 2.4 mg. Vomiting: 22% vs 16%. Dysesthesia: 22% vs 6%. Go in with eyes open.
Cold stop with structured habits
- Best for:
- High confidence in your habit base. Cost or supply forced the decision. Doctor-directed (pre-pregnancy, pre-surgery).
- Outlook:
- Regain is statistically likely. STEP 1 extension data is the honest baseline. The 90-day plan further down this page is what helps you beat the average.
- Trade-off:
- Don't romanticize willpower. Medication-stop regain is about 4× faster than diet-stop regain per BMJ 2026.
One critical label rule before you switch anything
Do not stack Wegovy with other GLP-1s. The Wegovy prescribing information says it should not be used with other semaglutide-containing products or other GLP-1 receptor agonists. If you are switching, you stop one and start the other on the schedule your prescriber gives you — never both at once.
Want a personalized version of this framework based on your dose and your reason for stopping? Our free quiz matches you to the path that fits.
Get your post-Wegovy action plan →What if I missed one dose, two doses, or several weeks of Wegovy?
Answer
Use the label's missed-dose rules, not guesses. For one missed weekly injection, take it as soon as possible if your next dose is more than 2 days away — or skip it if less than 2 days away. For 2 or more missed weekly injections in a row, the label says you may resume on schedule or, if needed, reinitiate dose escalation to reduce GI side effects. Always loop in your prescriber before restarting at a high dose after a long gap.
| Situation | What the Wegovy label says | Practical advice |
|---|---|---|
| Missed 1 injection, next dose is more than 2 days (48+ hours) away | Take the missed dose as soon as possible. | Then return to your normal weekly day next week. |
| Missed 1 injection, next dose is less than 2 days (under 48 hours) away | Skip the missed dose. | Take your next dose at your normal time. Don't double up. |
| Missed 2+ weekly injections in a row | You may resume on schedule, OR reinitiate dose escalation if needed. | Call your prescriber before restarting. Restarting too high after a gap is the most common cause of avoidable nausea. |
| Missed a Wegovy tablet (oral) | Skip the missed dose. Take your next dose the following day. | Don't double up. |
| Switching 2.4 mg injection → 25 mg tablet | Start the tablet one week after the last injection. | The 25 mg tablet is $299/month, not the $149 starting-dose price. |
| Switching 25 mg tablet → 2.4 mg injection | Take the first injection the next day after the last tablet. | Confirm timing with your prescriber. |
| Combining Wegovy with another GLP-1 | Not recommended per label. | Do not stack — stop one, start the other on your prescriber's schedule. |
| Source: Wegovy prescribing information. Verified May 4, 2026. | ||
Why restarting too high after a gap can backfire
Wegovy's titration schedule exists to reduce GI side effects. The ramp-up gives your stomach time to adapt to slowed gastric emptying. If you have been off for two months, your tolerance has reset. Hopping back on at 2.4 mg can mean a hard week of nausea that was avoidable. When in doubt: call your prescriber. A two-day delay is far less costly than a week of vomiting because you guessed.
Can you restart Wegovy after stopping?
Answer
Yes, most people can restart Wegovy after a break, but the right restart dose depends on how long you have been off, what dose you were on, why you stopped, and whether you had any side effects. The biggest practical mistake is restarting your old high dose after a long gap without your prescriber's input.
Bring these facts to the appointment:
- →Last dose date (write it down — phone calendars get messy)
- →Last dose amount (0.25, 0.5, 1.0, 1.7, 2.4, or 7.2 mg — or the pill dose)
- →Current weight and weight change since stopping
- →Reason you stopped (cost, side effects, goal weight, pregnancy, surgery, supply gap)
- →Any nausea, vomiting, or abdominal pain during your time on it
- →Blood sugar history if you're diabetic or pre-diabetic
- →Pregnancy or surgery status
- →Insurance status
When restart is not the right first move
- ✗Severe prior reaction to Wegovy (pancreatitis-like pain, allergic reaction, gallbladder symptoms)
- ✗Pregnancy or actively trying to conceive — discontinue at least 2 months before a planned pregnancy
- ✗Personal or family history of MTC or MEN 2 — boxed warning contraindication
- ✗Unresolved vomiting or dehydration from the previous course
- ✗Active gallbladder disease
What if you are stopping Wegovy because insurance stopped covering it?
Answer
Treat it as an access problem first, not a medication-stop decision. Coverage can sometimes be appealed or renewed. Other FDA-approved brand-name paths may be cheaper than you think. Check the options before you create a long medication gap.
Step 1 — Find out exactly why coverage ended
- •Prior authorization (PA) expired. Most PAs are 6 or 12 months. Renewal often just needs updated documentation.
- •BMI documentation got missed. The plan may need a current BMI from a recent visit.
- •Plan changed coverage rules (e.g., now requires step therapy with another GLP-1 first).
- •Employer dropped weight-loss medication coverage entirely.
- •You moved off a covered plan. Compare COBRA premium plus Wegovy copay against cash-pay before assuming either is cheaper.
Step 2 — Ask your prescriber about a PA renewal or appeal
Bring to the appointment: starting BMI and current BMI, weight-related conditions, total percent weight loss achieved, current dose and tolerance, and a continuity-of-care request if you have been on it for more than 6 months.
Step 3 — Compare brand-name cash-pay paths (verified )
| Path | Best fit | Current self-pay pricing | Watch-outs |
|---|---|---|---|
| Ro Body Program | Insurance coverage checking, FDA-approved GLP-1 access, PA concierge. | $39 first month, then as low as $74/month annual or $149/month monthly. Wegovy pill: $149 first month, $199–$299/month thereafter. Wegovy pen: $199 first month, $199–$349/month thereafter. | Membership cost is separate from medication cost. |
| Sesame Care | Maximum branded GLP-1 choice (Wegovy, Zepbound, Ozempic, Mounjaro, Foundayo). Provider choice matters. | Subscription as low as $59/month annual, medication not included. Wegovy pill: $149/month for 1.5 mg or 4 mg, $299/month for 9 mg or 25 mg. Wegovy pen: $199/month first two months for new patients, then $349/month. | Medication costs not included in subscription. Get an exact quote before committing. |
| NovoCare Pharmacy | You already have a prescriber and want manufacturer-direct cash pricing. | Wegovy pill: $149/month for 1.5 mg or 4 mg (4 mg promo through Aug 31, 2026, then $199/month); $299/month for 9 mg or 25 mg. Wegovy pen: $199/month new-patient promo for 0.25–0.5 mg through Jun 30, 2026; then $349/month for 0.25–2.4 mg; $399/month for 7.2 mg HD. | Promotional terms have expiration dates and eligibility rules. |
| Hims / Hers | Familiar consumer telehealth brand with FDA-approved GLP-1s. | Membership $39 first month, auto-renews $149/month. Medication billed separately. Carries Wegovy pill, Wegovy pen, and Ozempic post-March 2026 Novo Nordisk partnership. | FDA-approved focus only post-partnership. |
Worried about a coverage gap?
Ro's free GLP-1 Insurance Coverage Checker tells you what your plan will actually cover before you spend money. The concierge team handles prior authorization paperwork. Some links on this page are affiliate links — if you sign up, we may earn a commission. Editorial recommendations are independent.
Check your Wegovy coverage report with Ro → (sponsored affiliate link, opens in a new tab)Not sure if Ro is your best fit? See your full 2026 access map with our free matching quiz.
See your full 2026 access map →What if you are stopping Wegovy because of side effects?
Answer
Some Wegovy side effects ease quickly after stopping as the drug level falls. Severe symptoms are not something to self-manage. The Wegovy label warns about acute pancreatitis, gallbladder disease, dehydration-related kidney injury, severe GI reactions, and allergic reactions. Tell your prescriber what is happening before deciding whether to stop, switch, or reduce your dose.
Side effects that often ease after stopping
- ✓Nausea
- ✓Vomiting
- ✓Diarrhea
- ✓Constipation
- ✓Reflux and heartburn
- ✓Bloating and abdominal discomfort
- ✓General queasy/off feeling
Red flags — do not just stop and hope
- !Severe abdominal pain radiating to your back
- !Persistent vomiting or diarrhea with dehydration signs
- !Yellow skin or eyes, severe right-upper-belly pain
- !Allergic reaction signs (facial swelling, hives, trouble breathing)
- !Repeated low blood sugar on insulin or sulfonylureas
Dose reduction vs. stopping vs. switching
If side effects are dose-related (very common during titration), the answer may not be stopping at all:
- →Slow down the titration — many providers will hold a dose longer or step back one level
- →Switch the form — some patients tolerate the Wegovy pill better than the injection (or vice versa)
- →Switch the medication — a different GLP-1 like Zepbound has a different tolerability profile
What if you reached your goal weight?
Answer
Reaching your goal weight does not mean the biology that caused weight gain is gone. Maintenance is the harder phase. The decision is not “stop or stay on full dose forever.” It is which maintenance approach fits your situation.
Maintenance options to discuss with your prescriber
- •Continue at your current dose — simplest. Most regain protection. Highest ongoing cost.
- •Continue at a clinician-directed lower dose — some providers move patients to a lower dose for maintenance. Any extended-interval dosing is a clinician-directed off-label decision, not a labeled regimen.
- •Switch to the Wegovy pill — for cost or convenience. Same active ingredient, oral form. The label-aligned switch from 2.4 mg injection is to the 25 mg tablet at $299/month.
- •Stop with a structured monitoring plan — covered in the 90-day off-ramp section below.
Set a regain trigger before you stop
This is the single highest-leverage thing in this whole guide. People who stop without a predefined trigger usually wait too long to act. Examples:
- →If I regain 5% of my lowest weight, I'll book a provider visit within 7 days.
- →If my food noise score is 8+/10 for two consecutive weeks, I'll discuss restart options.
- →If my fasting glucose or A1c worsens, that's a trigger regardless of weight.
- →If my waist circumference increases by 2 inches, that's a trigger regardless of scale weight.
Write yours down. Tell your provider. Pin it to your bathroom mirror.
What if you need to stop for pregnancy or surgery?
Answer
For planned pregnancy, the Wegovy label says to stop at least 2 months before trying to conceive. For surgery involving anesthesia or deep sedation, tell your team early — Wegovy can delay gastric emptying. Current multi-society guidance from the American Society of Anesthesiologists says most patients can continue GLP-1s before elective surgery, but specific risk factors should be assessed individually.
Pregnancy planning
- •Stop at least 2 months before a planned pregnancy (Wegovy label instruction).
- •The Wegovy pill label specifically advises against breastfeeding during treatment with the tablet.
- •If you become pregnant unexpectedly while on Wegovy, contact your healthcare provider immediately.
- •Non-GLP-1 options and behavioral programs exist for the pre-conception phase.
Surgery & anesthesia
- •Tell your surgical and anesthesia team as soon as the surgery is scheduled — not the day of.
- •Current multi-society guidance (ASA, AGA, late 2024) says most patients can continue GLP-1s before elective surgery.
- •Your team will assess dose, last dose timing, procedure type, and pre-op fasting window.
- •Hiding GLP-1 use from anesthesia is the wrong move — complications have been reported.
How to reduce weight regain: your 12-week post-stop plan
Answer
There is no guaranteed way to prevent regain after stopping Wegovy, but a structured 12-week post-stop plan reduces panic and catches regain early. The plan is a monitoring scaffold — not a promise about exactly when hunger or regain starts. Use the four phases below as a structure for decisions, not a calendar of guaranteed feelings.
- Happening:
- ~50% of your last dose is still circulating after week 1. By end of week 2, about 25% remains.
- Monitor:
- Side effect changes, daily appetite, food noise score (0–10), weight at baseline.
- Action:
- Lock in a protein floor. Aim for 25–30g of protein per meal. Schedule your next provider check-in. Write down your current weight as your reference point.
- Happening:
- Drug down to ~12% by end of week 3. Around 3% by end of week 5.
- Monitor:
- Watch for rising food noise scores, hunger sooner after meals, cravings stronger than they used to be. This is the window to monitor — not panic.
- Action:
- If you are in 'I might restart' territory, this is the window to talk to your provider. Lock in habit infrastructure: protein at every meal, resistance training 2–3×/week, sleep target, stress baseline, weekly weigh-in.
- Happening:
- Per the label, semaglutide remains in circulation about 5 to 7 weeks after the last 2.4 mg or 7.2 mg dose. By week 7, most of it is gone.
- Monitor:
- Weight trend (compare to your week-1 reference, not day-to-day fluctuation). Food noise level. Sleep quality. Energy. Any return of pre-Wegovy symptoms.
- Action:
- If you are up by more than 3% of your weight from week 1, that is a signal to act, not panic. Book a provider visit.
- Happening:
- Per BMJ 2026, average regain pace for newer incretin medications is ~0.8 kg/month, with wide individual variation.
- Monitor:
- Trajectory, not single weigh-ins. Are you holding steady, drifting up, or accelerating?
- Action:
- Review your trajectory honestly. If regain is faster than you are comfortable with, the four off-ramp paths above are still available. The longer you wait past week 12, the harder course-correction gets.
What you should know about switching to another GLP-1 instead of stopping
If access is the problem but treatment is still appropriate, your prescriber may discuss switching to another FDA-approved medication rather than stopping completely.
Switching can be the right call when:
- →Your insurance doesn't cover Wegovy but covers another FDA-approved GLP-1 (Zepbound, Ozempic, Mounjaro)
- →Injection aversion is your main issue (Wegovy pill solves this — but check the dose-specific pricing: switching from 2.4 mg injection lands at the 25 mg tablet at $299/month, not $149)
- →A specific tolerability problem is dose-related rather than drug-class-related
- →You've plateaued and your provider wants to try tirzepatide (different mechanism)
If you came to Wegovy from compounded semaglutide and are considering going back, that is a different conversation worth doing carefully — see our switching guide:
Switching from compounded semaglutide to Wegovy: the complete guide →When to talk to your doctor — and what to ask
Loop in your prescribing provider before stopping or changing your Wegovy dose. Bring this checklist to the appointment:
- 1Given my dose and how long I've been on Wegovy, what does your recommended approach look like for stopping or stepping down?
- 2Is a maintenance dose an option for my situation? At what dose, what frequency?
- 3Should I consider switching to the Wegovy pill instead of stopping completely? Which dose would I switch to?
- 4How will we monitor my weight, blood pressure, and blood sugar after I stop?
- 5What signs would mean I should restart, and how would we do that safely?
- 6If insurance is the issue, can we appeal the denial together?
- 7Are there contraindications in my history that change any of this?
If your current prescriber does not offer maintenance dosing, the Wegovy pill, or insurance support, that is a routing signal. There are other FDA-approved telehealth providers who do. Sesame Care offers provider choice across the full branded GLP-1 formulary.
What we actually verified
Every claim above ties back to a primary source. Here is the list, with crawlable links. Last verified: .
| Claim | Source | Verified |
|---|---|---|
| Wegovy half-life ~7 days; remains in circulation 5–7 weeks after last 2.4 mg or 7.2 mg injection or 25 mg oral dose | Wegovy prescribing information (FDA) | May 4, 2026 |
| No clinically significant PK differences for body weight, renal, or hepatic impairment | Wegovy prescribing information | May 4, 2026 |
| STEP 1 extension: 17.3% loss → 11.6 pp regained → 5.6% net at week 120 | Wilding et al., Diabetes Obes Metab. 2022 | May 4, 2026 |
| STEP 4: Continued semaglutide −7.9% vs placebo-switch +6.9% from week 20–68 | Rubino et al., JAMA. 2021;325(14):1414-1425 | May 4, 2026 |
| BMJ 2026: 9,341 participants, 37 studies, ~0.8 kg/month for newer incretins, ~4× faster than behavioral-only stopping | West et al., BMJ. 2026;392:e085304 | May 4, 2026 |
| Missed-dose rules (2-day window); 2+ missed doses → resume or reinitiate escalation | Wegovy prescribing information | May 4, 2026 |
| 2.4 mg injection → 25 mg tablet: start tablet 1 week after last injection | Wegovy prescribing information | May 4, 2026 |
| Wegovy 7.2 mg HD: nausea 39% / vomiting 22% / dysesthesia 22% | Wegovy prescribing information | May 4, 2026 |
| Wegovy 25 mg tablet: −13.6% LSM body weight change vs −2.4% placebo at week 64 (Study 7) | Wegovy prescribing information | May 4, 2026 |
| Pre-pregnancy: discontinue Wegovy at least 2 months before planned pregnancy | Wegovy prescribing information | May 4, 2026 |
| Contraindications: MTC / MEN 2; serious hypersensitivity to semaglutide | Wegovy prescribing information | May 4, 2026 |
| Do not combine Wegovy with other semaglutide-containing products or GLP-1 receptor agonists | Wegovy prescribing information | May 4, 2026 |
| Pre-surgery: GLP-1 multi-society guidance | American Society of Anesthesiologists et al., 2024 | May 4, 2026 |
| NovoCare Wegovy pill self-pay: $149/month for 1.5 mg or 4 mg (4 mg promo through Aug 31, 2026); $299/month for 9 mg or 25 mg | NovoCare | May 4, 2026 |
| NovoCare Wegovy pen self-pay: $199/month new-patient promo (through Jun 30, 2026); $349/month for 0.25–2.4 mg; $399/month for 7.2 mg HD | NovoCare | May 4, 2026 |
| Ro: $39 first month, as low as $74/month annual or $149/month monthly | Ro pricing | May 4, 2026 |
| Sesame: as low as $59/month annual; Wegovy pill $149–$299/month dose-specific | Sesame Care weight loss program | May 4, 2026 |
| Hims & Hers FDA-approved access post-March 2026 Novo Nordisk partnership | Hims investor announcement | May 4, 2026 |
Frequently asked questions
Will I gain all the weight back if I stop Wegovy?
On average, people regain about two-thirds of their lost weight within a year of stopping if they have no continuation plan. STEP 1 extension data shows participants kept about 5.6% off their starting weight at week 120 even after stopping, so total regain is not guaranteed — but the trend is real. The BMJ 2026 meta-analysis projects most people return to their starting weight within about 1.5–2 years on average.
Do you have to taper off Wegovy?
No formal taper-off schedule is in the Wegovy prescribing information. Some providers recommend a gradual dose reduction anyway. Any lower-dose taper or extended-interval approach is a clinician-directed decision, not a labeled regimen. Talk to your prescriber.
How long does Wegovy stay in your system after the last dose?
About 5 to 7 weeks for full clearance after the last 2.4 mg or 7.2 mg injection or 25 mg oral dose, based on Wegovy's 7-day half-life. Half the dose is gone after one week, around 12% remains by week 3, and about 3% remains by week 5.
Does stopping Wegovy cause withdrawal symptoms?
No dependence-style withdrawal syndrome is described in the Wegovy prescribing information. What people experience is a rebound effect — appetite, food noise, and digestion returning to your pre-Wegovy state as the drug clears. If symptoms are severe or unusual (severe abdominal pain, persistent vomiting, allergic reaction signs), call your provider.
Can I just stop Wegovy cold turkey?
The label does not describe a dependence-withdrawal syndrome and does not require a formal taper. Whether you should cold-stop depends on why you are stopping and your situation — diabetes, cardiovascular disease, severe side effects, pregnancy, surgery, or a long gap before any restart all change the calculation.
What is the maintenance dose for Wegovy?
The labeled maintenance dose is 2.4 mg weekly. The maximum maintenance dose is Wegovy 7.2 mg weekly (Wegovy HD), available for patients who tolerate 2.4 mg for at least 4 weeks and need additional weight reduction. Some clinicians use a lower dose for personalized maintenance — that is a clinician-directed decision, not a labeled regimen.
How quickly do Wegovy side effects go away after stopping?
GI side effects can ease as the drug level falls. The label does not promise a specific resolution timeline. Severe symptoms should not be self-managed — they need medical attention.
Can I switch from the Wegovy injection to the Wegovy pill?
Yes. The Wegovy label says patients on the 2.4 mg injection may start the 25 mg tablet one week after their last injection. The 25 mg tablet costs $299 per month — not the $149 starting-dose price. The pill must be taken on an empty stomach with a 30-minute wait before food, drink, or other oral medications.
What if my insurance stopped covering Wegovy?
First, find out the specific reason for the denial. Then ask your prescriber about a prior authorization appeal or renewal. Then compare brand-name cash-pay paths (Ro, NovoCare, Sesame Care, Hims, Hers) before you create a long medication gap. Do not assume your only options are paying full retail or quitting.
Is compounded semaglutide the same thing as Wegovy?
No. Wegovy is an FDA-approved brand-name medication manufactured by Novo Nordisk. Compounded semaglutide is prepared by compounding pharmacies and is regulated differently. They are not interchangeable — that is a separate clinical and regulatory conversation with your prescriber.
Can I stop Wegovy for surgery?
Tell your surgical and anesthesia team early. Current multi-society guidance says most patients can continue GLP-1s before elective surgery, but specific risk factors should be assessed. Do not hide GLP-1 use from anesthesia.
Can I take Wegovy while trying to get pregnant?
No. The Wegovy label says to discontinue at least 2 months before a planned pregnancy and to discontinue when pregnancy is recognized. If you become pregnant unexpectedly while on Wegovy, contact your provider immediately.
The bottom line
Stopping Wegovy is not the cliff people think it is. The drug clears gradually. Hunger comes back gradually. Weight regain is a real risk — but it is not destiny, and the structure you build around the stop matters more than willpower.
- •Insurance loss → check coverage and brand-name cash-pay paths first.
- •Goal weight → set up maintenance dosing or a regain trigger.
- •Side effects → distinguish red flags from dose-related ones.
- •Pregnancy → stop 2 months out.
- •Surgery → tell your team early.
- •Missed doses → use the label rules.
- •Just want off → the 90-day off-ramp plan beats a cold stop most of the time.
Still not sure which GLP-1 program is right for you?
Take our free 60-second matching quiz. It asks about your goal, insurance, dose, reason for stopping, and budget — then returns a specific next step and the access path that actually fits.
Get my personalized GLP-1 plan →Related guides on The RX Index
About this page
- Created by:
- The RX Index Editorial Team
- About The RX Index:
- A pricing intelligence and comparison resource for GLP-1 telehealth providers.
- How this was produced:
- We compared current Wegovy FDA-label information from the prescribing information, primary-source clinical trial publications (NEJM, JAMA, Diabetes Obes Metab, BMJ), multi-society clinical guidance, and current telehealth provider pages, all verified .
- Affiliate disclosure:
- Some links on this page are affiliate links — if you sign up through them, we may earn a commission. Editorial recommendations are independent of any commercial relationship. We re-verify pricing and label-based claims on this page monthly.
- Last verified: